Page last updated: 2024-08-23

raloxifene hydrochloride and s 8932

raloxifene hydrochloride has been researched along with s 8932 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Baksi, S; Bojkova, D; Ciesek, S; Cinatl, J; Claussen, C; Das, S; DeLong, LN; Domingo-Fernández, D; Ebeling, C; Eils, R; Fröhlich, H; Gadiya, Y; Gardner, S; Geisslinger, G; Gribbon, P; Hoeng, J; Hofmann-Apitius, M; Jacobs, M; Karki, R; Kodamullil, AT; Lage-Rupprecht, V; Lentzen, M; Lukassen, S; Peitsch, M; Raschka, T; Ravindra, NG; Reinshagen, J; Schultz, B; Strivens, M; van Dijk, D; Zaliani, A	1

Other Studies

1 other study(ies) available for raloxifene hydrochloride and s 8932

Article	Year
A method for the rational selection of drug repurposing candidates from multimodal knowledge harmonization. Scientific reports, 2021, 05-26, Volume: 11, Issue:1 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Combined Modality Therapy; Computational Biology; COVID-19 Drug Treatment; Drug Repositioning; Drug Synergism; Drug Therapy, Combination; GTP Phosphohydrolases; Humans; Knowledge Bases; Nelfinavir; Pandemics; Raloxifene Hydrochloride; SARS-CoV-2	2021

Article

Year

A method for the rational selection of drug repurposing candidates from multimodal knowledge harmonization.

Scientific reports, 2021, 05-26, Volume: 11, Issue:1

Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Combined Modality Therapy; Computational Biology; COVID-19 Drug Treatment; Drug Repositioning; Drug Synergism; Drug Therapy, Combination; GTP Phosphohydrolases; Humans; Knowledge Bases; Nelfinavir; Pandemics; Raloxifene Hydrochloride; SARS-CoV-2

2021